HCMT
CRL icon

Highland Capital Management (Tennessee)’s Charles River Laboratories CRL Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,869
Closed -$975K – 312
2019
Q2 		$975K Buy
+6,869
New +$932K 0.07% 217
2019
Q1 		– Sell
-11,006
Closed -$1.25M – 325
2018
Q4 		$1.25M Buy
+11,006
New +$1.38M 0.11% 183
2017
Q2 		– Sell
-7,204
Closed -$648K – 361
2017
Q1 		$648K Sell
7,204
-1,792
-20% -$152K 0.05% 235
2016
Q4 		$685K Sell
8,996
-2,705
-23% -$205K 0.06% 237
2016
Q3 		$975K Buy
11,701
+133
+1% +$11.1K 0.08% 222
2016
Q2 		$954K Buy
+11,568
New +$953K 0.08% 211

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return